Reason for request
Inscription
Clinical Benefit
| Substantial |
Le service médical rendu par les spécialités IMIPENEM CILASTATINE STRAVENCON 250 mg/250 mg et 500 mg/500 mg, poudre pour solution pour perfusion, est important dans les indications de l’AMM.
|
Clinical Added Value
| no clinical added value |
Absence d’amélioration du service médical rendu (ASMR V, inexistante) par rapport à TIENAM 500mg/500mg, poudre pour perfusion.
|
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
qFfPdpjDvegzpgS5